Thomas Adams - Insider Trading & Ownership

Entity
Individual
Summary
The estimated net worth of Thomas Adams is at least $1.24M dollars as of June 14, 2021. Thomas Adams is the Former Director of Cardiff Oncology, Inc. and owns shares of Cardiff Oncology, Inc. (CRDF) stock worth about $1.24M.
All Insider Reports
All Insider Reports

Ownership of Thomas Adams

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CRDF Cardiff Oncology, Inc. Former Director $1.24M Jun 10, 2021
HEPA, CTRVP Hepion Pharmaceuticals, Inc. Director May 18, 2021

Insider Transactions Reported by Thomas Adams:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.